NCT01971112

Brief Summary

Poor Ecuadorian older people suffer from chronic dietary deficiencies of zinc, iron, copper, vitamins C, B6, B12, D, and folic acid. The investigators have previously shown that these deficiencies are associated with impaired immune function and increased incidence of respiratory infections (RI). The hypothesis is that correction of these specific nutrient deficiencies will improve immune response and thereby enhance resistance to respiratory infections. To test this hypothesis this study will evaluate the effect of supplementation with specific vitamins and minerals found to be deficient in poor elderly Ecuadorians on markers of immune function and the incidence of RI. A randomized, double-blind, placebo-controlled trial in 320 older people (≥65 y)will be carried out in Quito, Ecuador. Participants will receive multivitamin and mineral supplements or placebo tablets daily for 12 months. Nutrients will be provided at US Recommended Daily Allowance (RDA) levels, except for vitamin C and zinc doses, which will be 5 times and 1.25 times higher than the RDA, respectively. Incidence of respiratory infections (the primary outcome) will be assessed weekly by field nurses and physicians from the study team. Secondary outcomes include delayed-type hypersensitivity (DTH) skin test, cathelicidin production by mucosa respiratory cells, and serum C-reactive protein (CRP) as measures of immune function. Blood micronutrient levels and haemoglobin status will be collected as measures of adherence to the trial regimen. Incidence rate of RI and rate ratio (RR) will be calculated to quantify the effect of the intervention on the incidence of respiratory infection. This will be the first trial of its kind conducted specifically in a population of older people known to have poor micronutrient status. The findings of the study may be important for similar populations in other low- and middle-income countries.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
320

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2013

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

October 10, 2013

Completed
19 days until next milestone

First Posted

Study publicly available on registry

October 29, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

October 29, 2013

Status Verified

October 1, 2013

Enrollment Period

1 year

First QC Date

October 10, 2013

Last Update Submit

October 23, 2013

Conditions

Keywords

Multi-vitaminsMineralsRespiratory infectionsDTHCRPCathelicidin

Outcome Measures

Primary Outcomes (1)

  • Incidence of respiratory infections (upper plus lower)

    52 weeks

Secondary Outcomes (3)

  • Mean score of DTH response to Trichophyton and tetanus toxoid

    52 weeks

  • CRP blood concentration

    52 weeks

  • Cathelicidin concentration in supernatants of cultured respiratory mucosa cells

    52 weeks

Study Arms (2)

Multivitamins and minerals

EXPERIMENTAL

Experimental: X: Multivitamins and minerals (MVM) Arm X: 1X US-RDA of vitamins A, D,E,B6,B12, folate, copper and iron plus 500 mg vitamin C, and 14 mg of Zinc

Dietary Supplement: Multivitamins and minerals

Placebo

PLACEBO COMPARATOR
Dietary Supplement: Multivitamins and minerals

Interventions

Multivitamins and mineralsDIETARY_SUPPLEMENT

Dietary supplement Arm X: Vitamins B6, B12,folic acid, A, D, E, and Iron, and copper at one US-RDA. Plus vitamin C 500 mg, and zinc 14 mg will be given orally daily during 52 weeks.

Multivitamins and mineralsPlacebo

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥65 years
  • Mental competence
  • Written informed consent

You may not qualify if:

  • Cancer
  • Tuberculosis
  • Immunosuppressive therapeutics.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atucucho neighborhood

Quito, Pichincha, Ecuador

RECRUITING

Related Publications (3)

  • Sempertegui F, Estrella B, Tucker KL, Hamer DH, Narvaez X, Sempertegui M, Griffiths JK, Noel SE, Dallal GE, Selhub J, Meydani SN. Metabolic syndrome in the elderly living in marginal peri-urban communities in Quito, Ecuador. Public Health Nutr. 2011 May;14(5):758-67. doi: 10.1017/S1368980010002636. Epub 2010 Oct 19.

    PMID: 20955641BACKGROUND
  • Hamer DH, Sempertegui F, Estrella B, Tucker KL, Rodriguez A, Egas J, Dallal GE, Selhub J, Griffiths JK, Meydani SN. Micronutrient deficiencies are associated with impaired immune response and higher burden of respiratory infections in elderly Ecuadorians. J Nutr. 2009 Jan;139(1):113-9. doi: 10.3945/jn.108.095091. Epub 2008 Dec 3.

    PMID: 19056665BACKGROUND
  • Sempertegui F, Estrella B, Elmieh N, Jordan M, Ahmed T, Rodriguez A, Tucker KL, Hamer DH, Reeves PG, Meydani SN. Nutritional, immunological and health status of the elderly population living in poor neighbourhoods of Quito, Ecuador. Br J Nutr. 2006 Nov;96(5):845-53. doi: 10.1017/bjn20061802.

    PMID: 17092372BACKGROUND

MeSH Terms

Conditions

Respiratory Tract Infections

Interventions

GeritolMinerals

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Inorganic Chemicals

Central Study Contacts

Fernando E Sempertegui, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 10, 2013

First Posted

October 29, 2013

Study Start

October 1, 2013

Primary Completion

October 1, 2014

Study Completion

December 1, 2014

Last Updated

October 29, 2013

Record last verified: 2013-10

Locations